Qiming U.S. Healthcare Fund II, L.P. - Aug 2, 2021 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Former 10% Owner
Signature
/s/ Qiming U.S. Healthcare Fund II, L.P., by Qiming U.S. Healthcare GP II, LLC, its General Partner
Stock symbol
ICVX
Transactions as of
Aug 2, 2021
Transactions value $
$3,320,265
Form type
4
Date filed
8/2/2021, 09:27 PM
Previous filing
Jul 28, 2021
Next filing
Oct 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Conversion of derivative security $0 +3.31M $0.00 3.31M Aug 2, 2021 Direct F1, F2
transaction ICVX Common Stock Purchase $3M +200K +6.04% $15.00 3.51M Aug 2, 2021 Direct F2, F5
transaction ICVX Common Stock Purchase $120K +8.02K +0.23% $15.00 3.52M Aug 2, 2021 Direct F3
transaction ICVX Common Stock Purchase $200K +13.3K +0.38% $15.00 3.52M Aug 2, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Series A-1 Preferred Stock Conversion of derivative security -12.5M -100% 0 Aug 2, 2021 Common Stock 3M $0.00 Direct F1, F2
transaction ICVX Series B-1 Preferred Stock Conversion of derivative security -1.28M -100% 0 Aug 2, 2021 Common Stock 307K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Qiming U.S. Healthcare Fund II, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. ("Qiming") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer.
F2 The securities are directly held by Qiming. Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming. Gary Rieschel and Mark McDade are the managing members of Qiming GP. As a result, each of Qiming GP and Messrs. Rieschel and McDade may be deemed to beneficially own the shares held by Qiming.
F3 Shares reported herein as purchased on August 2, 2021 represent 8,018 shares of Common Stock purchased by Mark McDade.
F4 Shares reported herein as purchased on August 2, 2021 represent 13,333 shares of Common Stock purchased by Gary Rieschel.
F5 Shares reported herein as purchased on August 2, 2021 represent 200,000 shares of Common Stock purchased by Qiming.